Holen Sie sich die Stockscreener-App
96.00
1.14%
1.08
Handel nachbörslich:
94.61
-1.39
-1.45%
Schlusskurs vom Vortag:
$94.92
Offen:
$95.4
24-Stunden-Volumen:
398.49K
Relative Volume:
0.90
Marktkapitalisierung:
$2.08B
Einnahmen:
$486.82M
Nettoeinkommen (Verlust:
$18.78M
KGV:
117.07
EPS:
0.82
Netto-Cashflow:
$100.45M
1W Leistung:
+3.75%
1M Leistung:
+46.72%
6M Leistung:
+62.35%
1J Leistung:
+52.53%
1-Tages-Spanne:
$94.80
$96.37
1-Wochen-Bereich:
$91.97
$96.37
52-Wochen-Spanne:
$52.50
$96.37
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
Ani Pharmaceuticals Inc
Sektor
Telefon
(218) 634-3500
Adresse
210 MAIN STREET WEST, BAUDETTE, MN
Vergleichen Sie ANIP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
96.00 | 2.04B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-03-12 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-15 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-02 | Eingeleitet | Truist | Buy |
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy |
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy |
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold |
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy |
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral |
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral |
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform |
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Bestätigt | ROTH Capital | Buy |
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform |
Alle ansehen
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Fed Meeting: Is ANI Pharmaceuticals Inc. stock forming a cup and handleCEO Change & Safe Entry Trade Signal Reports - khodrobank.com
What Fibonacci levels say about ANI Pharmaceuticals Inc. reboundTrade Exit Summary & AI Based Buy and Sell Signals - Newser
Should you hold or exit ANI Pharmaceuticals Inc. nowNew Guidance & Safe Entry Trade Reports - Newser
What to do if you’re stuck in ANI Pharmaceuticals Inc.2025 Historical Comparison & Reliable Intraday Trade Plans - Newser
Is this a good reentry point in ANI Pharmaceuticals Inc.Portfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Sector ETF performance correlation with ANI Pharmaceuticals Inc.Weekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Can machine learning forecast ANI Pharmaceuticals Inc. recoveryJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Forecasting ANI Pharmaceuticals Inc. price range with options dataWeekly Investment Report & Safe Capital Growth Tips - Newser
Best data tools to analyze ANI Pharmaceuticals Inc. stock2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
Is ANI Pharmaceuticals Inc. stock good for income investorsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - khodrobank.com
Published on: 2025-09-02 23:11:03 - Newser
What machine learning models say about ANI Pharmaceuticals Inc.Risk Management & Daily Profit Maximizing Tips - Newser
What’s the profit margin of ANI Pharmaceuticals Inc.2025 Geopolitical Influence & Verified Short-Term Plans - khodrobank.com
Recovery Signals Appearing in ANI Pharmaceuticals Inc. ChartsTake Profit & Weekly Momentum Stock Picks - beatles.ru
What data driven models say about ANI Pharmaceuticals Inc.’s futureWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Is ANI Pharmaceuticals Inc. the Top Chart Pick This Week2025 Analyst Calls & Consistent Profit Alerts - beatles.ru
Generic Pharmaceuticals Stocks Q2 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Best of the Bunch - Yahoo Finance
ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch - Yahoo Finance
Evaluating ANI Pharmaceuticals Inc. with trendline analysisMarket Activity Summary & Risk Controlled Swing Trade Alerts - Newser
Is ANI Pharmaceuticals Inc. exposed to currency risksJuly 2025 Setups & Verified Chart Pattern Signals - khodrobank.com
Will ANI Pharmaceuticals Inc. outperform tech stocksJuly 2025 Rallies & Expert Approved Momentum Ideas - khodrobank.com
Is ANI Pharmaceuticals Inc.’s growth already priced inNew Guidance & Weekly Breakout Opportunity Watchlist - khodrobank.com
Tools to assess ANI Pharmaceuticals Inc.’s risk profileMarket Performance Summary & Daily Momentum Trading Reports - Newser
What is the next catalyst for ANI Pharmaceuticals Inc.Portfolio Value Report & Technical Buy Zone Confirmations - khodrobank.com
Is now the right time to enter ANI Pharmaceuticals Inc.July 2025 Chart Watch & Detailed Earnings Play Alerts - khodrobank.com
Using R and stats models for ANI Pharmaceuticals Inc. forecastingBuy Signal & Reliable Volume Spike Trade Alerts - Newser
Leading vs lagging indicators on ANI Pharmaceuticals Inc. performanceWatch List & Verified Momentum Stock Alerts - Newser
Is ANI Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Earnings & AI Enhanced Market Trend Forecasts - Newser
Pattern recognition hints at ANI Pharmaceuticals Inc. upsideTrade Volume Report & Real-Time Chart Breakout Alerts - Newser
Can trapped investors hope for a rebound in ANI Pharmaceuticals Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Published on: 2025-08-30 23:50:13 - Newser
Applying big data sentiment scoring on ANI Pharmaceuticals Inc.2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser
Can a trend reversal in ANI Pharmaceuticals Inc. lead to recoveryWeekly Profit Summary & Reliable Intraday Trade Alerts - Newser
Published on: 2025-08-30 20:33:47 - Newser
Is ANI Pharmaceuticals Inc. the Top Chart Pick This Week getLinesFromResByArray error: size == 0 - thegnnews.com
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ani Pharmaceuticals Inc-Aktie (ANIP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Leonard Matthew J | Director |
Aug 25 '25 |
Sale |
90.62 |
2,528 |
229,087 |
6,864 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):